|
Immtech
International Inc
|
Nasdaq
Immtech
International, Inc. is a pharmaceutical company advancing the development
and commercialization of oral drugs to treat infectious diseases, neoplastic
(cancer) and metabolic (diabetes) disorders. We are developing treatments
for treatments for diseases such as malaria, Pneumocystis pneumonia, fungal
infections, tuberculosis and hepatitis, and tropical diseases such as African
sleeping sickness and leishmaniasis. We have a worldwide, exclusive
license to commercialize a dicationic pharmaceutical platform from which
a pipeline of products may be developed to target large, global markets.
150 Fairway Drive, Suite
150 Vernon Hills, IL 60061
Phone: (847) 573-0033 Fax:
(847) 573-8288
August 05 2005 Immtech
Reports Fiscal First Quarter 2006 Results PDF
|